Blockchain Registration Transaction Record

HeartBeam Advances Heart Attack Detection, Reports Q2 2026 Results

HeartBeam (NASDAQ: BEAT) reports Q2 2026 results, completing enrollment in ALIGN-ACS study, advancing 12-lead ECG patch, and launching commercial sales.

HeartBeam's progress in developing a portable 3D ECG device could revolutionize how heart attacks and arrhythmias are detected, potentially saving lives by enabling timely intervention outside traditional medical settings. For investors, the completion of key clinical milestones and initial commercial rollout signal the company's transition from development to market entry, which could lead to significant growth opportunities in the cardiac monitoring space.